Clinical outcomes of switching to aflibercept using a pro re nata treatment regimen in patients with neovascular age-related macular degeneration who incompletely responded to ranibizumab

BACKGROUND: To assess the effect of switching patients previously incompletely treated with ranibizumab (RBZ) to aflibercept (AFL) using a pro re nata (PRN) treatment strategy in neovascular age-related macular degeneration (nvAMD). METHODS: A retrospective case series was conducted on patients who...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:BMC Ophthalmol
Autori principali: Elwes, Flora, Borooah, Shyamanga, Aspinall, Peter, Sim, Peng Yong, Loo, Cheng Yi, Armbrecht, Ana-Maria, Dhillon, Baljean, Cackett, Peter
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2018
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5789603/
https://ncbi.nlm.nih.gov/pubmed/29378528
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12886-018-0688-3
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi